With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Hereâs why they are bullish on them:
Aristocrat Leisure Limited (ASX: ALL)
According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $43.00 price target on this gaming technology companyâs shares. This follows news that Aristocratâs real money gaming (RMG) business has signed a deal with BetMGM for digital slot content. BetMGM believes the deal will makes its online casino the best destination for players. Morgan Stanley believes this is a big positive for Aristocrat and its fledgling RMG business. The Aristocrat share price is trading at $35.70 on Monday.
Healthco Healthcare and Wellness REIT (ASX: HCW)
A note out of Morgans reveals that its analysts have retained their add rating on this property companyâs shares with an improved price target of $2.06. This follows the release of the companyâs half year results, which revealed a solid operational performance. Morgans appears positive on the future, highlighting its active development pipeline (Springfield and Proxima) and the uncommitted developments which include strategic partners. The Healthco share price is fetching $1.55 today.
Objective Corporation Limited (ASX: OCL)
Analysts at Goldman Sachs have retained their buy rating but trimmed their price target on this software companyâs shares to $14.80. Although Objective Corpâs half year results came in below expectations on both ARR growth and costs/margins, Goldman believes the company has reached an earnings trough after making the decision to reduce its one-off revenue sources and reinvest into growth initiatives. The Objective Corp share price is trading at $12.48 this afternoon.
The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
FREE Guide for New Investors
Despite what some people may say – we believe investing in shares doesn’t have to be overwhelming or complicated…
For over a decade, we’ve been helping everyday Aussies get started on their journey.
And to help even more people cut through some of the confusion “experts’” seem to want to perpetuate – we’ve created a brand-new “how to” guide.
Yes, Claim my FREE copy!
*Returns as of February 1 2023
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Get 5%+ yields from these top ASX dividend shares: experts
- Broker names the best ASX tech shares to buy now
- Top ASX growth shares to buy in February 2023
- Why did this ASX lithium share just rocket 42%?
- Leading brokers name 3 ASX shares to buy today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Objective. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/OCPAV9U